The global human immunoglobulin market is anticipated to grow at a significant CAGR of 6.4% during the forecast period. Hypogammaglobulinemia is considered a problem with the immune system that prevents it from making enough antibodies that are known as immunoglobulins. So, a large increase in the prevalence of hypogammaglobulinemia disorders around the globe is a considered major factor that is driving the growth of the market. Additionally, COVID-19 infection is common in cancer patients, especially those with hematologic malignancies. Protective measures against COVID-19 infection were high in primary immunodeficiencies (PIDs) patients with hypogammaglobulinemia following Ig replacement medication, according to a study published in the Journal of Clinical Immunology 2021. COVID-19 infection was also a problem among female patients with primary immunodeficiencies and hypogammaglobulinemia which remained for a long period of time, therefore, it is anticipated that the infectious hepatitis market will grow in the future. For instance, in April 2019, the US Food and Drug Administration (FDA) has given approval to ADMA Biologics Inc.'s ASCENIV, a novel intravenous immunoglobulin for the treatment of primary humoral immunodeficiency disorder. Moreover, in May 2020, Octapharma AG US investigational new drug (IND) application for a phase three clinical trial on the efficacy and safety of Octagam 10% [Immune Globulin Intravenous (Human)] therapy in COVID-19 patients with severe disease progression was authorized by the US Food and Drug Administration (FDA).

Get Sample Copy of this Report at

https://www.omrglobal.com/request-sample/human-immunoglobulin-market

Impact of COVID-19 Pandemic on Global Human Immunoglobulin Market

The COVID-19 had a favorable impact on the human immunoglobulin market, as there have been more research studies on immunoglobulins for providing effective treatment for COVID-19. In March 2021, according to the National Clinical Trials (NCT) Registry, there are currently around 50 immunoglobulin-based clinical trials in various stages of development in the US which have a positive impact on the market due to which it could lead to the development of new effective COVID-19 therapy in the near future.

Inquire for Discount on this Report at

https://www.omrglobal.com/report-customization/human-immunoglobulin-market

Segmental Outlook

The global human immunoglobulin market is segmented based on the type and disease indication. Based on the type, the market is segmented into liquid and powder. Based on the disease indication, the market is sub-segmented into infectious hepatitis and Measles. Among these, the disease indication segment is anticipated to propel the growth of the market over the forecast period, owing to the growth in the prevalence of immunodeficiency illnesses, increasing immunoglobulin adoption, and expanded research and development activities.

By Type (Liquid and Powder),

By Disease Indication (Infectious hepatitis and Measles)

Market Players Outlook

The major companies serving the global human immunoglobulin market include Baxter International Inc., CSL Ltd., Grifols S.A., Kedrion Biopharma Inc., Octapharma AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2019, ADMA Biologics, Inc. announced that the US Food and Drug Administration (FDA) had notified ADMA the licenses for BIVIGAM and Nabi-HB have been revoked from Biotest Pharmaceuticals Corp. (BPC) US License No. 1792 and transferred and issued to ADMA’s US License No. 2019.

The Report Covers

Market value data analysis of 2021 and forecast to 2028.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global human immunoglobulin market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying ‘who-stands-where’ in the market.

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404